About Us

Matt Callahan

CEO

Industry Experience

22 years

Prior Experience

Glycan Bioscience LLC

Orthocell Ltd

Botanix Pharma Inc.

Mr. Callahan is the founding CEO of Churchill Pharmaceuticals and a co-inventor of some of the technologies that comprise the SoluMatrix Fine Particle Technology™.

He has led the development of the company’s product pipeline and the creation of Churchill’s market entry strategy. Matt has more than 18 years of corporate leadership, legal, licensing and investment management experience.

Matt has worked as an investment director for two venture capital firms investing in life sciences, clean technology and other sectors. He was the founding CEO of iCeutica Inc. and co-founder of Glycan Bioscience LLC, Orthocell Ltd (ASX:OCC) and Botanix Pharma Inc.


CEO

22 years of experience

CSO

20 years of experience

President

25 years of experience

Senior Vice President,
Commercial

30 years of experience

Senior Vice President,
General Counsel

20 years of experience

Vice President,
Sales

30 years of experience

Vice President,
Market Access

30 years of experience

Vice President,
Marketing

30 years of experience

Executive Director,
Human Resources

20 years of experience